  Anti-apoptotic Bcl-2 proteins are upregulated in different cancers , including diffuse large B-cell lymphoma ( DLBCL) and chronic lymphocytic leukemia<disease> ( CLL) , enabling survival by inhibiting pro-apoptotic Bcl-2-family members and inositol 1,4,5-trisphosphate ( IP